Pharmacokinetics of Tamsulosin Hydrochloride in Patients with Renal Impairment: Effects of α1-Acid Glycoprotein-Reference-Cited by-同舟云学术

Pharmacokinetics of Tamsulosin Hydrochloride in Patients with Renal Impairment: Effects of α1-Acid Glycoprotein

Published:1996-11 Issue:11 Volume:36 Page:1029-1038
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Koiso Kenkichi,Akaza Hideyuki,Kikuchi Koji,Aoyagi Kazumasa,Ohba Shoji,Miyazaki Mitsuhiro,Ito Mitsue,Sueyoshi Toshiyuki,Matsushima Hiroshi,Kamimura Hidetaka,Watanabe Takashi,Higuchi Saburo

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. Alpha-1 adrenoceptor antagonistic effects of the optical isomers of YM-12617 in rabbit lower urinary tract and prostate;Honda;J Pharmacol Exp Ther,1986

2. Further studies on (+)-YM-12617, a potent and selective α-adrenoceptor anatgonist and its individual optical enantiomers;Honda;Naunyn Schmiedebergs Arch Pharmacol,1987

3. Alpha-1-acid glycoprotein concentrations and propranolol binding in elderly patients with acute illness;Paxton;Br J Clin Pharmacol,1984

4. Glycoproteins and human cancer. I. Circulating levels in cancer serum;Lipton;Cancer,1979

5. Altered plasma drug binding in cancer: role of alpha-1-acid glycoprotein and albumin;Jackson;Clin Pharmacol Ther,1982

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin to related CYP2D6*10 allele;ARCH PHARM RES;2021

2. Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele;Archives of Pharmacal Research;2021-11

3. Pharmacokinetics and tolerability of fedratinib, an oral, selective Janus kinase 2 inhibitor, in subjects with renal or hepatic impairment;Cancer Chemotherapy and Pharmacology;2020-05-24

4. The effect of elevated α1-acid glycoprotein on the pharmacokinetics of TAK-272 (SCO-272), an orally active renin inhibitor, in rats;Xenobiotica;2018-06-25

5. Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans;European Journal of Clinical Pharmacology;2018-06-13